McGrane Nicholas 4
4 · Evolent Health, Inc. · Filed Mar 5, 2019
Insider Transaction Report
Form 4
McGrane Nicholas
Chief Financial Officer
Transactions
- Award
Class A Common Stock Option (right to buy)
2019-03-01+57,741→ 57,741 totalExercise: $13.29Exp: 2029-03-01→ Class A Common Stock (57,741 underlying) - Award
Class A Common Stock
2019-03-01+30,098→ 84,088 total
Footnotes (4)
- [F1]Represents restricted stock units granted to Mr. McGrane pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
- [F2]Securities vest at a rate of 25% annually beginning March 1, 2020.
- [F3]Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F4]Securities vest at a rate of 25% annually beginning March 1, 2020.